We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders (BIVV009-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02502903
Recruitment Status : Completed
First Posted : July 20, 2015
Last Update Posted : April 25, 2022
Celerion Clinical Research GmbH
Assign Data Management and Biostatistics GmbH
ABF Pharmaceutical Services GmbH
Quest Diagnostics-Nichols Insitute
Covance Laboratories - Chantilly
PPD Laboratories - Virginia
Softworld Inc. - Cambridge, MA
Information provided by (Responsible Party):
Sanofi ( Bioverativ, a Sanofi company )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 31, 2021
Actual Study Completion Date : March 31, 2021